ICDCode | Description |
240. | Simple and unspecified goiter |
240.0 | Simple Goiter |
240.9 | Goiter |
241. | Nontoxic nodular goiter |
241.0 | Nontoxic uninodular goiter; thyroid nodule |
241.1 | Nontoxic multinodular goiter |
241.9 | Unspecified nontoxic nodular goiter; thyroid nodule |
242. | Thyrotoxicosis with or without goiter |
242.0 | Toxic goiter; Graves' disease |
242.00 | Toxic diffuse goiter without mention of thyrotoxic crisis or storm |
242.01 | Tox Dif Goiter W Crisis |
242.1 | Toxic uninodular goiter |
242.10 | Tox Uninod Goit No Cris |
242.11 | Tox Uninod Goit W Crisis |
242.2 | Toxic multinodular goiter |
242.20 | Tox Multnod Goit No Cris |
242.21 | Tox Multnod Goit W Cris |
242.3 | Toxic nodular goiter, unspecified |
242.30 | Tox Nod Goiter No Crisis |
242.31 | Tox Nod Goiter W Crisis |
242.4 | Thyrotoxicosis from ectopic thyroid nodule |
242.40 | Thyrotox-ect Nod No Cris |
242.41 | Thyrotox-ect Nod W Cris |
242.8 | Thyrotoxicosis of other specified origin |
242.80 | Thyrtox Orig Nec No Cris |
242.81 | Thyrotox Orig Nec W Cris |
242.9 | Thyrotoxicosis without mention of goiter or other cause; hyperthyroidism |
242.90 | Thyrotoxicosis without mention of goiter or other cause |
242.91 | Thyrotox Nos W Crisis |
243. | Congenital hypothyroidism |
244. | Acquired hypothyroidism |
244.0 | Postsurgical hypothyroidism |
244.1 | Postablat Hypothyr Nec |
244.2 | Iodine Hypothyroidism |
244.3 | Iatrogen Hypothyroid Nec |
244.8 | Other specified acquired hypothyroidism |
244.9 | Unspecified acquired hypothyroidism |
245. | Thyroiditis |
245.0 | Acute Thyroiditis |
245.1 | Subacute thyroiditis |
245.2 | Hashimoto Thyroiditis; Autoimmune Thyroiditis; Autoimmune Thyroid Disease |
245.3 | Chr Fibrous Thyroiditis |
245.4 | Iatrogenic Thyroiditis |
245.8 | Chr Thyroiditis Nec/nos |
245.9 | Thyroiditis Nos |
246. | Other disorders of thyroid |
246.0 | Dis Thyrocalciton Secret |
246.1 | Dyshormonogenic Goiter |
246.2 | Thyroid cyst; parathyroid cyst |
246.3 | Hemorr/infarc Thyroid |
246.8 | Disorders Of Thyroid Nec |
246.9 | Unspecified disorder of thyroid |
249. | Secondary diabetes mellitus |
249.0 | Secondary diabetes mellitus without mention of complication |
249.00 | Secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified |
249.01 | Secondary diabetes mellitus without mention of complication, uncontrolled |
249.1 | Secondary diabetes mellitus with ketoacidosis |
249.10 | Secondary diabetes mellitus with ketoacidosis, not stated as uncontrolled, or unspecified |
249.11 | Secondary diabetes mellitus with ketoacidosis, uncontrolled |
249.2 | Secondary diabetes mellitus with hyperosmolarity |
249.20 | Secondary diabetes mellitus with hyperosmolarity, not stated as uncontrolled, or unspecified |
249.21 | Secondary diabetes mellitus with hyperosmolarity, uncontrolled |
249.30 | Secondary diabetes mellitus with other coma, not stated as uncontrolled, or unspecified |
249.31 | Secondary diabetes mellitus with other coma, uncontrolled |
249.40 | Secondary diabetes mellitus with renal manifestations, not stated as uncontrolled, or unspecified |
249.41 | Secondary diabetes mellitus with renal manifestations, uncontrolled |
249.50 | Secondary diabetes mellitus with ophthalmic manifestations, not stated as uncontrolled, or unspecified |
249.51 | Secondary diabetes mellitus with ophthalmic manifestations, uncontrolled |
249.6 | Secondary diabetes mellitus with neurological manifestations |
249.60 | Secondary diabetes mellitus with neurological manifestations, not stated as uncontrolled, or unspecified |
249.61 | Secondary diabetes mellitus with neurological manifestations, uncontrolled |
249.70 | Secondary diabetes mellitus with peripheral circulatory disorders, not stated as uncontrolled, or unspecified |
249.71 | Secondary diabetes mellitus with peripheral circulatory disorders, uncontrolled |
249.8 | Secondary diabetes mellitus with other specified manifestations |
249.80 | Secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified |
249.81 | Secondary diabetes mellitus with other specified manifestations, uncontrolled |
249.9 | Secondary diabetes mellitus with unspecified complications |
249.90 | Secondary diabetes mellitus with unspecified complication, not stated as uncontrolled, or unspecified |
249.91 | Secondary diabetes mellitus with unspecified complication, uncontrolled |
250. | Diabetes mellitus |
250.0 | Diabetes mellitus without mention of complications |
250.00 | Diabetes mellitus type 2 (NIDDM, noninsulin-dependent or unspecified) |
250.01 | Diabetes mellitus type 1 (IDDM, insulin-dependent, juvenile) |
250.02 | Diabetes with hyperosmolarity |
250.03 | Diabetes mellitus without mention of complications (IDDM uncontrolled) |
250.1 | Diabetes with ketoacidosis |
250.10 | Type 2 diabetes mellitus with ketoacidosis |
250.11 | Type 1 diabetes mellitus with ketoacidosis |
250.12 | Diabetes with ketoacidosis, type 2 or unspecified type, uncontrolled |
250.13 | Diabetes with ketoacidosis (IDDM uncontrolled) |
250.2 | Diabetes with hyperosmolarity |
250.20 | Type 2 diabetes mellitus with hyperosmolar coma |
250.21 | Type 1 diabetes mellitus with hyperosmolar coma |
250.22 | Dmii Hprosmlr Uncontrold |
250.23 | Dmi Hprosmlr Uncontrold |
250.3 | Diabetes with other coma |
250.30 | Dmii O Cm Nt St Uncntrld |
250.31 | Dmi O Cm Nt St Uncntrld |
250.32 | Dmii Oth Coma Uncontrold |
250.33 | Dmi Oth Coma Uncontrold |
250.4 | Diabetes with renal manifestations; diabetic nephropathy |
250.40 | Type 2 diabetes mellitus with renal manifestations |
250.41 | Type 1 diabetes mellitus with renal manifestations |
250.42 | diabetes with renal manifestations (NIDDM) |
250.43 | Dmi Renal Uncntrld |
250.5 | Diabetes with ophthalmic manifestations (diabetic retinopathy) |
250.50 | Type 2 diabetes mellitus with ophthalmic manifestations |
250.51 | Type 1 diabetes mellitus with ophthalmic manifestations |
250.52 | Dmii Ophth Uncntrld |
250.53 | Diabetes with ophthalmic manifestations (IDDM uncontrolled) |
250.6 | Diabetes with neurological manifestations (diabetic neuropathy) |
250.60 | Type 2 diabetes mellitus with neurological manifestations |
250.61 | Type 1 diabetes mellitus with neurological manifestations |
250.62 | Diabetes with neurological manifestations (NIDDM uncontrolled) |
250.63 | Dmi Neuro Uncntrld |
250.7 | Diabetes with peripheral circulatory disorders |
250.70 | Type 2 diabetes mellitus with peripheral circulatory disorders |
250.71 | Type 1 diabetes mellitus with peripheral circulatory disorders |
250.72 | Diabetes with peripheral circulatory disorders (NIDDM uncontrolled) |
250.73 | Dmi Circ Uncntrld |
250.8 | Diabetes with other specified manifestations |
250.80 | Type 2 diabetes mellitus with other specified manifestations |
250.81 | Type 1 diabetes mellitus with other specified manifestations |
250.82 | Dmii Oth Uncntrld |
250.83 | Diabetes with other specified manifestations (IDDM uncontrolled) |
250.9 | Diabetes with unspecified complications |
250.90 | Type 2 diabetes mellitus with unspecified complications |
250.91 | Type 1 diabetes mellitus with unspecified complications |
250.92 | Diabetes with unspecified complications (NIDDM uncontrolled) |
250.93 | Diabetes with unspecified complications (IDDM uncontrolled) |
251. | Other disorders of pancreatic internal secretion |
251.0 | Hypoglycemic coma |
251.1 | Other specified hypoglycemia; hyperinsulinemia |
251.2 | Hypoglycemia, unspecified |
251.3 | Postsurg Hypoinsulinemia |
251.4 | Abn Secretion Glucagon |
251.5 | Abnormality of secretion of gastrin (pancreatic hyperplasia, Zollinger-Ellison syndrome) |
251.8 | Other specified disorders of pancreatic internal secretion |
251.9 | Pancreatic Disorder Nos |
252. | Parathyroid disorder |
252.0 | Hyperparathyroidism |
252.00 | Hyperparathyroidism, unspecified |
252.01 | Primary hyperparathyroidism |
252.02 | Secondary hyperparathyroidism, non-renal |
252.08 | Other hyperparathyroidism |
252.1 | Hypoparathyroidism |
252.8 | Other specified disorders of parathyroid gland (cyst, hemorrhage) |
252.9 | Parathyroid Disorder Nos |
253. | Disorders of the pituitary gland and its hypothalamic control |
253.0 | Acromegaly and gigantism |
253.1 | Other and unspecified anterior pituitary hyperfunction; hyperprolactinemia |
253.2 | Panhypopituitarism; hypopituitarism |
253.3 | Growth Hormone Deficiency; Pituitary Dwarfism |
253.4 | Kallmann's syndrome |
253.5 | Diabetes insipidus (vasopressin deficiency) |
253.6 | Other disorders of neurohypophysis |
253.7 | Iatrogenic Pituitary Dis |
253.8 | Pituitary Disorder Nec |
253.9 | Pituitary Disorder Nos |
254. | Diseases of thymus gland |
254.0 | Persist Hyperplas Thymus |
254.1 | Abscess Of Thymus |
254.8 | Diseases Of Thymus Nec |
254.9 | Disease Of Thymus Nos |
255. | Disorders of adrenal glands |
255.0 | Cushing disease (Cushing syndrome) |
255.1 | Hyperaldosteronism; aldosteronism |
255.10 | Primary aldosteronism |
255.11 | Glucocorticoid-remediable aldosteronism |
255.12 | Conn's syndrome |
255.13 | Bartter's syndrome |
255.14 | Other secondary aldosteronism |
255.2 | Adrenogenital disorders; congenital adrenal hyperplasia |
255.3 | Corticoadren Overact Nec |
255.4 | Corticoadrenal insufficiency; Addison's disease |
255.41 | Glucocorticoid deficiency |
255.42 | Mineralocorticoid deficiency |
255.5 | Adrenal insufficiency; Addison's disease; adrenal hypofunction |
255.6 | Medulloadrenal Hyperfunc |
255.8 | Other specified disorders of adrenal glands |
255.9 | Adrenal Disorder Nos |
256. | Ovarian dysfunction |
256.0 | Hyperestrogenism |
256.1 | Ovarian Hyperfunc Nec |
256.2 | Postablativ Ovarian Fail |
256.3 | Other ovarian failure; premature ovarian failure (primary ovarian insufficiency) |
256.31 | Premature Menopause |
256.39 | Ovarian Failure Nec |
256.4 | Polycystic ovary (PCOS); polycystic ovary syndrome |
256.8 | Ovarian Dysfunction Nec |
256.9 | Ovarian Dysfunction Nos |
257. | Testicular dysfunction |
257.0 | Testicular Hyperfunction |
257.1 | Postablat Testic Hypofun |
257.2 | Other testicular hypofunction; hypogonadism; androgen deficiency; testosterone deficiency |
257.8 | Other testicular dysfunction (Goldberg-Maxwell syndrome; testicular feminization) |
257.9 | Testicular Dysfunct Nos |
258. | Polyglandular dysfunction and related disorders |
258.0 | Wermers Syndrome |
258.01 | Multiple endocrine neoplasia (MEN) type I |
258.02 | Multiple endocrine neoplasia [MEN] type IIA |
258.03 | Multiple endocrine neoplasia [MEN] type IIB |
258.1 | Comb Endocr Dysfunct Nec |
258.8 | Other specified polyglandular dysfunction; autoimmune polyglandular syndrome (APS) |
258.9 | Polyglandul Dysfunc Nos |
259. | Other endocrine disorders |
259.0 | Delay Sexual Develop Nec |
259.1 | Precocious sexual development and puberty; precocious puberty (pseudoprecocious puberty) |
259.2 | Carcinoid syndrome |
259.3 | Ectopic hormone secretion, not elsewhere classified; hyperfunctioning parathyroids |
259.4 | Dwarfism, not elsewhere classified |
259.5 | Androgen insensitivity syndrome |
259.50 | Androgen insensitivity, unspecified |
259.51 | Androgen insensitivity syndrome |
259.52 | Partial androgen insensitivity |
259.8 | Other specified endocrine disorders |
259.9 | Unspecified endocrine disorder, (hormone disturbance NOS) |
260. | Kwashiorkor |
261. | Nutritional marasmus |
262. | Other severe protein-calorie malnutrition |
263. | Other and unspecified protein-calorie malnutrition |
263.0 | Malnutrition of moderate degree |
263.1 | Malnutrition of mild degree |
263.2 | Arrest Devel Due To Malnutr |
263.8 | Other protein-calorie malnutrition |
263.9 | Unspecified protein-calorie malnutrition |
264. | Vitamin A deficiency |
264.0 | Vit A Conjunctiv Xerosis |
264.1 | Vit A Bitots Spot |
264.2 | Vit A Corneal Xerosis |
264.3 | Vit A Cornea Ulcer/xeros |
264.4 | Vit A Keratomalacia |
264.5 | Vit A Night Blindness |
264.6 | Vit A Def W Corneal Scar |
264.7 | Vit A Ocular Defic Nec |
264.8 | Vitamin A Deficiency Nec |
264.9 | Vitamin A deficiency not otherwise specified |
265. | Thiamine and niacin deficiency states |
265.0 | Beriberi |
265.1 | Thiamine Defic Nec/nos |
265.2 | Pellagra |
266. | Deficiency of B-complex components |
266.0 | Ariboflavinosis |
266.1 | Vitamin B6 Deficiency |
266.2 | Other B-complex deficiencies |
266.9 | Vitamin B deficiency not otherwise specified |
267. | Vitamin C deficiency; ascorbic acid deficiency |
268. | Vitamin D deficiency (hypovitaminosis D, 25-hydroxyvitamin D) |
268.0 | Rickets |
268.1 | Rickets, Late Effect |
268.2 | Osteomalacia Nos |
268.9 | Vitamin D Deficiency Nos |
269. | Other nutritional deficiencies |
269.0 | Vitamin K deficiency |
269.1 | Vitamin Deficiency Nec |
269.2 | Vitamin Deficiency Nos |
269.3 | Iodine deficiency; zinc deficiency; mineral deficiency not elsewhere classified |
269.8 | Nutrition Deficiency Nec |
269.9 | Unspecified nutritional deficiency |
270. | Disorders of amino-acid transport and metabolism |
270.0 | Disturbances of amino-acid transport |
270.1 | Phenylketonuria (PKU) |
270.2 | Other disturbances of aromatic amino acid metabolism (albinism; alkaptonuria; tyrosinemia) |
270.3 | Disturbances of branched-chain amino-acid metabolism; maple syrup urine disease |
270.4 | Homocystinuria; homocystinemia; disturbances of sulfur-bearing amino-acid metabolism |
270.5 | Dis Histidine Metabolism |
270.6 | Urea cycle disorder; argininemia; citrullinemia; hyperammonemia; ornithine transcarbamylase deficiency; glutaric acidemia (glutaric aciduria) |
270.7 | Straig Amin-acid Met Nec |
270.8 | Other specified disorders of amino acid metabolism; glutaric aciduria; hydroxyprolinemia |
270.9 | Dis Amino-acid Metab Nos |
271. | Disorders of carbohydrate transport and metabolism |
271.0 | Glycogenosis; glycogen storage disease type 2 (Pompe disease) |
271.1 | Galactosemia |
271.2 | Hereditary fructose intolerance |
271.3 | Lactose intolerance; lactase deficiency |
271.4 | Renal Glycosuria |
271.8 | Other specified disorders of carbohydrate transport and metabolism; primary hyperoxaluria |
271.9 | Dis Carbohydr Metab Nos |
272. | Disorders of lipoid metabolism |
272.0 | Hypercholesterolemia (cholesterol elevation); dyslipidemia (lipid abnormality); high density lipoprotein (HDL); low density lipoprotein (LDL) |
272.00 | Familial hypercholesterolemia; familial hypertriglyceridemia |
272.1 | Pure hypertriglyceridemia |
272.2 | Mixed hyperlipidemia |
272.3 | Hyperchylomicronemia |
272.4 | Other and unspecified hyperlipidemia |
272.5 | Lipoprotein Deficiencies |
272.6 | Lipodystrophy |
272.7 | Lipidoses; Gaucher disease; Fabry disease (Anderson-Fabry disease) |
272.8 | Other disorders of lipoid metabolism |
272.9 | Unspecified disorder of lipoid metabolism |
273. | Disorders of plasma protein metabolism |
273.0 | Polyclonal hypergammaglobulinemia |
273.1 | Monoclonal paraproteinemia; monoclonal gammopathy of undetermined significance (MGUS) |
273.2 | Other paraproteinemias; cryoglobulinemia |
273.3 | Macroglobulinemia; Waldenstrom macroglobulinemia |
273.4 | Alpha-1-antitrypsin deficiency |
273.8 | Other disorders of plasma protein metabolism |
273.9 | Dis Plas Protein Met Nos |
274. | Gout |
274.0 | Gouty arthropathy |
274.00 | Gouty arthropathy, unspecified |
274.01 | Acute gouty arthropathy |
274.02 | Chronic gouty arthropathy without mention of tophus (tophi) |
274.03 | Chronic gouty arthropathy with tophus (tophi) |
274.1 | Gouty nephropathy |
274.10 | Gouty Nephropathy Nos |
274.11 | Uric Acid Nephrolithias |
274.19 | Gouty Nephropathy Nec |
274.8 | Gout with other specified manifestations |
274.81 | Gouty Tophi Of Ear |
274.82 | Gouty Tophi Site Nec |
274.89 | Gout W Manifestation Nec |
274.9 | Gout, unspecified |
275. | Disorders of mineral metabolism; Wilson disease; hepatolenticular degeneration |
275.0 | Disorders of iron metabolism; hemochromatosis |
275.1 | Disorders of copper metabolism; Wilson disease |
275.2 | Disorders of magnesium metabolism |
275.3 | Disorders of phosphorus metabolism |
275.4 | Disorders of calcium metabolism |
275.40 | Unspecified disorder of calcium metabolism |
275.41 | Hypocalcemia |
275.42 | Hypercalcemia |
275.49 | Other disorders of calcium metabolism |
275.5 | Hungry bone syndrome |
275.8 | Dis Mineral Metabol Nec |
275.9 | Dis Mineral Metabol Nos |
276. | Disorders of fluid, electrolyte, and acid-base balance |
276.0 | Hyperosmolality; hypernatremia |
276.1 | Hyposmolality and/or hyponatremia (sodium deficiency) |
276.2 | Acidosis |
276.3 | Alkalosis |
276.4 | Mixed acid-base balance disorder |
276.5 | Volume depletion disorder (hypovolemia; dehydration) |
276.50 | Volume depletion, unspecified |
276.51 | Dehydration |
276.52 | Hypovolemia; Depletion of volume of plasma |
276.6 | Fluid overload disorder |
276.7 | Hyperkalemia (hyperpotassemia) |
276.8 | Hypokalemia (hypopotassemia) |
276.9 | Electrolyte and fluid disorders not elsewhere classified |
277. | Other and unspecified disorders of metabolism |
277.0 | Cystic fibrosis |
277.00 | Cystic fibrosis without mention of meconium ileus |
277.01 | Cystic Fibrosis W Ileus |
277.02 | Cystic Fibros W Pul Man |
277.03 | Cystic Fibrosis W Gi Man |
277.09 | Cystic Fibrosis Nec |
277.1 | Disorders of porphyrin metabolism; porphyria |
277.2 | Other disorders of purine and pyrimidine metabolism |
277.3 | Amyloidosis |
277.30 | Amyloidosis, unspecified |
277.31 | Familial Mediterranean fever |
277.39 | Other amyloidosis |
277.4 | Disorders of bilirubin excretion |
277.5 | Mucopolysaccharidosis |
277.6 | Other deficiencies of circulating enzymes; hereditary angioedema |
277.60 | Biotinidase Deficiency |
277.7 | Metabolic syndrome |
277.8 | Other specified disorders of metabolism |
277.81 | Primary carnitine deficiency |
277.82 | Carnitine deficiency due to inborn errors of metabolism |
277.83 | Iatrogenic carnitine deficiency |
277.84 | Other secondary carnitine deficiency |
277.85 | Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency; Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency; Very Long-Chain Acyl-CoA Dehydrogenase Deficiency |
277.86 | Peroxisomal disorders; leukodystrophy; adrenoleukodystropy; Zellweger syndrome |
277.87 | Disorders of mitochondrial metabolism |
277.88 | Tumor lysis syndrome |
277.89 | Other specified disorders of metabolism |
277.9 | Unspecified disorder of metabolism |
278. | Obesity and other hyperalimentation |
278.0 | Obesity; overweight |
278.00 | Obesity Nos |
278.01 | Morbid obesity (severe obesity) |
278.02 | Morbid obesity; Severe obesity |
278.1 | Localized adiposity |
278.2 | Hypervitaminosis A |
278.3 | Hypercarotinemia |
278.4 | Hypervitaminosis D |
278.8 | Other hyperalimentation |
279. | Disorders involving the immune mechanism |
279.0 | Deficiency of humoral immunity |
279.00 | Other hypogammaglobulinemia; X-linked agammaglobulinemia; hypogammaglobulinemia |
279.01 | Selective IgA immunodeficiency; immunoglobulin A deficiency (IgA deficiency); immunoglobulin A nephritis (IgA nephritis); immunoglobulin A nephropathy (IgA nephropathy) |
279.02 | Selective IgM immunodeficiency; immunoglobulin M deficiency (IgM deficiency); hyper immunoglobulin M (IgM) |
279.03 | IgG4-Related Disease; Immunoglobulin G (IgG); Immunoglobulin G Deficiency (IgG Deficiency) |
279.04 | Cong Hypogammaglobulinem |
279.05 | Immunodefic W Hyper-igm |
279.06 | Primary immunodeficiency; common variable immunodeficiency (CVID) |
279.07 | Immunoglobulin E (IgE); Hyper-Immunoglobulin E (IgE) |
279.09 | Humoral Immunity Def Nec |
279.1 | Deficiency of cell-mediated immunity |
279.10 | Immundef T-cell Def Nos |
279.11 | Digeorges Syndrome |
279.12 | Wiskott-Aldrich syndrome |
279.13 | Nezelofs Syndrome |
279.19 | Defic Cell Immunity Nos |
279.2 | Combined immunity deficiency |
279.3 | Unspecified immunity deficiency |
279.4 | Autoimmune disease not elsewhere classified |
279.41 | Autoimmune lymphoproliferative syndrome |
279.49 | Autoimmune disease, not elsewhere classified |
279.5 | Graft-versus-host disease |
279.50 | Graft-versus-host disease, unspecified |
279.51 | Acute graft-versus-host disease |
279.52 | Chronic graft-versus-host disease |
279.53 | Acute on chronic graft-versus-host disease |
279.8 | Other specified disorders involving the immune mechanism; immunodeficiency disease |
279.9 | Immune Mechanism Dis Nos |